Charles & Colvard, Ltd. Stock Price, Forecast & Analysis (NASDAQ:CTHR)

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Charles & Colvard, Ltd. (NASDAQ:CTHR) issued its quarterly earnings results on Thursday, November, 7th. The company reported $0.01 EPS for the quarter. The company earned $7.61 million during the quarter, compared to analysts' expectations of $7.19 million. Charles & Colvard, Ltd. had a return on equity of 6.06% and a net margin of 7.14%. View Charles & Colvard, Ltd.'s Earnings History.

1 Wall Street analysts have issued 1 year target prices for Charles & Colvard, Ltd.'s stock. Their forecasts range from $2.50 to $2.50. On average, they anticipate Charles & Colvard, Ltd.'s share price to reach $2.50 in the next twelve months. This suggests a possible upside of 72.4% from the stock's current price. View Analyst Price Targets for Charles & Colvard, Ltd..

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Charles & Colvard, Ltd..

News coverage about CTHR stock has been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Charles & Colvard, Ltd. earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Charles & Colvard, Ltd..

Charles & Colvard, Ltd. saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 226,700 shares, an increase of 7.8% from the September 30th total of 210,300 shares. Based on an average trading volume of 98,500 shares, the days-to-cover ratio is presently 2.3 days. Currently, 0.9% of the company's shares are sold short. View Charles & Colvard, Ltd.'s Current Options Chain.

Some companies that are related to Charles & Colvard, Ltd. include RYB Education (RYB), Peak Resorts (SKIS), Bassett Furniture Industries (BSET), Gaia (GAIA), Escalade (ESCA), Civeo (CVEO), Townsquare Media (TSQ), China Online Education Group (COE), Lifetime Brands (LCUT), Universal Technical Institute (UTI), Flexsteel Industries (FLXS), Dorel Industries (DIIBF), LRAD (LRAD), Fujian Blue Hat Interactive Entertainment Technology (BHAT) and Urban One (UONE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Allena Pharmaceuticals (ALNA), Flexion Therapeutics (FLXN), Adamis Pharmaceuticals (ADMP), Amarin (AMRN), Biocept (BIOC), Catalyst Biosciences (CBIO), Clearside Biomedical (CLSD), Corbus Pharmaceuticals (CRBP), Evolus (EOLS) and Gemphire Therapeutics (GEMP).

Charles & Colvard, Ltd.'s stock is owned by many different of retail and institutional investors. Top institutional investors include National Investment Services Inc. WI (0.17%). Company insiders that own Charles & Colvard, Ltd. stock include Anne M Butler, Benedetta I Casamento, Clint J Pete, Don O'connell, Jaqui Lividini, Ollin B Sykes and Suzanne Miglucci. View Institutional Ownership Trends for Charles & Colvard, Ltd..

CTHR stock was purchased by a variety of institutional investors in the last quarter, including National Investment Services Inc. WI. Company insiders that have bought Charles & Colvard, Ltd. stock in the last two years include Benedetta I Casamento, Clint J Pete, Don O'connell, Jaqui Lividini, Ollin B Sykes and Suzanne Miglucci. View Insider Buying and Selling for Charles & Colvard, Ltd..

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTHR stock can currently be purchased for approximately $1.45.

Charles & Colvard, Ltd. has a market capitalization of $42.02 million and generates $32.24 million in revenue each year. The company earns $2.27 million in net income (profit) each year or $0.10 on an earnings per share basis. Charles & Colvard, Ltd. employs 59 workers across the globe.View Additional Information About Charles & Colvard, Ltd..

The official website for Charles & Colvard, Ltd. is http://www.charlesandcolvard.com/.

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at 919-468-0399 or via email at [email protected]